Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|December 7, 2025
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily C Merkel, Ted Gooley, Monica S Thakar, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 23, 2024
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple MyelomaRahul Banerjee, Andrew J Cowan, Marivel Ortega, et al.
Transplantation and Cellular Therapy|January 24, 2025
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell TransplantationBlachy J Dávila Saldaña, Kirk R Schultz, Archana Ramgopal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2012
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host diseaseJeanne M Palmer, Stephanie J Lee, Xiaoyu Chai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2010
Unrelated donor bone marrow transplantation for myelodysplastic syndrome in childrenPaul Woodard, Paul A Carpenter, Stella M Davies, et al.
Transplantation and Cellular Therapy|September 22, 2024
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular TherapyRaheel Iftikhar, Zachariah DeFilipp, Amy E DeZern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host diseaseAreej El-Jawahri, Joseph Pidala, Yoshi Inamoto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2016
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines CommitteeJeanne Palmer, Jeannine S McCune, Miguel-Angel Perales, et al.
Blood|June 18, 2016
Genetic risk factors for sclerotic graft-versus-host diseaseYoshihiro Inamoto, Paul J Martin, Mary E D Flowers, et al.
Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.
Pageof 18